Caliber Imaging & Diagnostics, Inc. (LCDX)
Caliber Imaging & Diagnostics, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Andover, MA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $5,104. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -164.0%. Its beta of 0.46 implies it has historically moved less than the broad market.
Caliber Imaging & Diagnostics, Inc. is a U.S.-based medical technology firm that develops, manufactures, and markets advanced imaging solutions designed to visualize tissue at a cellular resolution. Their product line features the VivaScope 1500, a reflectance confocal imaging system that empowers medical practitioners and scientists to capture detailed confocal images depicting the cellular architecture of living tissue. They also provide the VivaScope 3000, a handheld in vivo reflectance confocal microscope tailored for dermatological imaging. Complementing its hardware, the firm offers VivaScan software, which streamlines patient scheduling, facilitates multi-lesion imaging during appointments, and assists with image review and reporting. Additionally, they supply VivaNet, a sophisticated digital telepathology system. Initially established as Lucid, Inc. in 1991, the company rebranded as Caliber Imaging & Diagnostics, Inc. in August 2012 and is headquartered in Andover, Massachusetts.
Caliber Imaging & Diagnostics, Inc. is most often compared with the following Healthcare names: